All entries on Feminist Legal Clinic’s News Digest Blog are extracts from news articles and other publications, with the source available at the link at the bottom. The content is not originally generated by Feminist Legal Clinic and does not necessarily reflect our views.
Hepatitis C destroys the liver slowly, the way water ruins wood, not all at once but over years, often unnoticed until it’s advanced. The woman in the biopsy room had the virus, a history of intravenous drug use, and a liver that was telling the story of both. Her doctors were trying to understand how much damage had been done and whether treatment had helped. They took a tissue sample, prepared it under fluorescence, and began examining the cells.
What they saw didn’t make sense. Their slides appeared to be full of male cells, morphologically perfect and indistinguishable from the surrounding liver tissue.
The male cells in her diseased liver had come from a son she had chosen to terminate 19 years earlier.
He had never drawn a breath. He had never had a name. But for nearly two decades, his cells had apparently been living in her body, and when her liver began to fail, his cells had gone there, taken on the shape and function of hepatic tissue, and done their work.
The cells of the child she had terminated were reaching across the years to heal her body. Even though he had not been given a chance at life, he was, in the only way available to him, trying to give his mother one.
The researchers published this in the journal Hepatology in 2002. They described the cells as a potential “alternate source of tissue repair.” They called it the first documented case of fetal cell microchimerism in association with an infectious disease and said the finding, if replicated, had significant implications.
What they uncovered next changed how scientists understand pregnancy entirely.
The phenomenon of fetal microchimerism is something most people have never heard of. During pregnancy, a small number of fetal cells cross the placenta and enter the mother’s bloodstream. They circulate. Then they find somewhere to land. Researchers have found them in maternal hearts, livers, brains, thyroids, kidneys, bone marrow, skin, and lungs. They don’t stay as generic cells; they differentiate, taking on the characteristics of whatever tissue surrounds them. A fetal cell that lands in the liver starts behaving like a liver cell. A fetal cell that reaches the heart can, apparently, start beating like one.
And they stay. In women who have carried sons, researchers can detect Y-chromosome DNA in maternal tissues not for weeks or months but for decades. A 2004 study in The Lancet found fetal stem cells in the bone marrow of women whose last pregnancy with a male child had been more than fifty years earlier. When researchers autopsied the brains of women between 32 and 101 years old, they found their children’s DNA in 63 percent of the samples. The oldest woman carrying her child’s cells in her brain was 94. She had likely been carrying them since the year her son was born and she went to her grave with a piece of him still there.
The exchange runs the other direction, too. A mother’s cells also cross into the fetus, embed in the child’s developing tissues, and can remain there for years after birth.
In other words, from very early in pregnancy, a mother and her child are sustaining each other in a complex, symbiotic relationship that neither of them controls. The process begins weeks before she may even know she is pregnant, and it does not end when the pregnancy does.
The most striking evidence of what fetal cells appear to do involves the heart. Every year, thousands of pregnant and postpartum women develop peripartum cardiomyopathy, a life-threatening form of heart failure that strikes during or just after pregnancy. For most people who experience this kind of cardiac crisis, the outcome is grim: transplant or worse. For these women, something different happens. Roughly half of them recover, the highest recovery rate of any heart failure population in medicine. For years, nobody could explain it.
A mother and child are not two separate organisms who happen to share a space for nine months. They are, at the cellular level, a permanent exchange. They are building each other, healing each other, carrying each other long after the pregnancy ends. This science is a direct threat to one very large and very profitable industry.
The surrogacy industry’s central marketing claim, present on the websites of clinics and agencies across the country, is that a gestational carrier has no biological connection to the child she carries.
Fetal microchimerism does not care about the contract, however. A gestational surrogate carrying a genetically unrelated embryo still exchanges cells with the child she carries. The mechanism is placental, not genetic. Her cells cross into the baby. The baby’s cells cross into her. They may embed in her brain, her heart, her bone marrow, and remain there for decades. The child will leave, by contractual obligation. A living fragment of that child (its own cells) will not.
